Statements of Cash Flows - USD ($)	7 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (10,092,969)	$ 20,875,863
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	8,717,310	(23,966,470)
Financing costs - derivative warrant liabilities	1,281,140
Net gain from investments held in Trust Account	(253,315)	(175,706)
Changes in operating assets and liabilities:
Prepaid expenses	(247,305)	152,262
Accounts payable	4,000	377,616
Accrued expenses	38,120	1,085,460
Franchise tax payable	110,187	(11,224)
Income tax payable	30,057	(30,057)
Net cash used in operating activities	(412,775)	(1,692,256)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(575,000,000)
Net cash used in investing activities	(575,000,000)
Cash Flows from Financing Activities:
Proceeds from working capital loan		600,000
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from note payable to related party	200,000
Proceeds received from initial public offering, gross	575,000,000
Proceeds received from private placement	13,500,000
Offering costs paid	(12,038,086)	(85,000)
Net cash provided by financing activities	576,686,914	515,000
Net increase (decrease) in cash	1,274,139	(1,177,256)
Cash - beginning of the period		1,274,139
Cash - end of the period	1,274,139	96,883
Supplemental disclosure of noncash activities:
Offering costs included in accrued expenses	85,000
Deferred underwriting commissions in connection with the initial public offering	$ 20,125,000